Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

Reference Listed Drug Labeling and Efficacy Supplements Approved in July 2002
Click on appropriate hyperlink below to view available source document in PDF format

Approval

Date

Product Name

Source Documents

Active Ingredient(s)/Dosage Form

Document ID No.
Jul 2

FORTOVASE

letter label

saquinavir capsule

20-828 SLR 010
   

INVIRASE

letter label

saquinavir mesylate capsule

20-628 SLR 016
Jul 3

HIVID

letter label

zalcitabine tablet

20-199 SLR 014
Jul 5

CLOZARIL

letter    

clozapine tablet

19-758 SLR 048
  

CORTIFOAM

letter label

hydrocortisone acetate rectal aerosol

17-351 SLR 027
   

DEFINITY

letter    

perflutren injection

21-064 SLR 002
Jul 8

ISOVUE

letter    

iopamidol injection

18-735 SLR 043
   

OMNISCAN

letter    

gadodiamide injection

20-123 SLR 018
   

TESLASCAN

letter    

mangafodipir trisodium injection

20-652 SLR 003

LONITEN

letter label

minoxidil tablet

18-154 SLR 023
Jul 9

M.V.I. PEDIATRIC

letter label

multi-vitamins injection

18-920 SLR 024
   

TAXOTERE

letter    

docetaxel injection

20-449 SLR 017
Jul 11

GLUCAGEN

letter    

glucagon (rDNA origin) injection

20-918 SLR 003

ACTOS

letter label

pioglitazone tablet

21-073 SE8 010
   

AREDIA

letter    

pamidronate disodium injection

20-036 SE8 026
Jul 12

HABITROL

letter label

nicotine transdermal system

20-076 SLR 020
   

PRAVACHOL

letter label

pravastatin Na tablets

19-898 SLR 050
   

PRILOSEC

letter label

omeprazole delayed-release capsule

19-810 SE5 074

CLEOCIN T

letter label

clindamycin phophate topical solution

50-600 SLR 002
Jul 14

CLEOCIN T

letter label

clindamycin phophate gel

50-615 SLR 003
   

CLEOCIN T

letter label

clindamycin phophate lotion

50-537 SLR 013
   

RENOVA

letter label

tretinoin cream

21-108 SLR 001
Jul 15

HABITROL

letter label

nicotine transdermal system

20-076 SLR 021

ELOCON

letter label

mometasone furoate cream

19-625 SE5 013
   

ELOCON

letter label

mometasone furoate lotion

19-543 SE5 013
   

ELOCON

letter label

mometasone furoate ointment

19-796 SE5 015
Jul 17

LEVOXYL

letter    

levothyroxine Na tablets

21-301 SLR 002
   

NASONEX

letter label

mometasone furoate nasal spray

20-762 SE5 011
   

SPORANOX

letter label

itraconazole injection

20-966 SLR 006
   

SPORANOX

letter label

itraconazole oral solution

20-657 SLR 008
   

SPORANOX

letter label

itraconazole capsules

20-083 SLR 028
   

ZYLOPRIM

letter    

allopurinol tablets

16-084 SLR 041
Jul 18

MANDOL

letter    

cefamandole nafatate injection

50-504 SLR 059

ACCUPRIL

letter    

quinaprilHCl tablets

19-885 SLR 019
   

ZITHROMAX

letter    

azithromycin single dose

50-693 SLR 007
Jul 22

ZITHROMAX

letter    

azithromycin tablet

50-730 SLR 010
   

ZITHROMAX

letter    

azithromycin injection

50-733 SLR 010
   

ZITHROMAX

letter    

azithromycin capsule

50-670 SLR 019
   

ZITHROMAX

letter    

azithromycin oral susp

50-710 SLR 014
Jul 23

DOBUTREX

letter    

dobutamine injectioin

17-820 SLR 037
   

NICOTROL

letter    

nicotine transdermal system

20-536 SLR 010

AGGRASTAT

letter    

tirofiban injection

20-913 SLR 008
   

AGGRASTAT

letter    

tirofiban injection

20-912 SLR 009
Jul 24

CEFTIN

letter    

cefuroxime axetil tablets

50-605 SLR 037
   

OMNICEF

letter    

cefdinir capsules

50-739 SLR 006
   

SANDOSTATIN

letter    

octreotide acetate injection

19-667 SLR 032
Jul 25

FOSAMAX

letter label

alendronate Na tablets

20-560 SLR 031

PROZAC

letter label

fluoxetine HCl tablets

20-974 SE8 001
Jul 29

PROZAC

letter label

fluoxetine HCl oral solution

20-101 SE8 027
   

PROZAC

letter label

fluoxetine HCl capsules

18-936 SE1 061
Jul 30

AZULFIDINE

letter    

sulfasalazine tablets

07-073 SLR 120
   

TAXOTERE

letter label

docetaxel injection

20-449 SLR 019

ALEVE COLD & SINUS

letter    

naproxen Na/pseudoephedrine HCl ER tablets

21-076 SLR 007
Jul 31

MIGRANAL

letter label

dihydroergotamine nasal spray

20-148 SLR 008
   

PREVACID

letter label

lansoprazole delayed-release capsule

20-406 SE5 047

totop.gif (1525 bytes) Back to Top

Back Labeling Review Branch Page

FDA/Center for Drug Evaluation and Research
Last Updated: April 20, 2006
Originator: OTCOM/DLIS
HTML by JFG